These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pharmacokinetics of sisomicin in patients with normal and impaired renal function; its efficacy in urinary tract infection. Roth S; Naber K; Scheer M; Gruenwaldt G; Lange H Eur J Clin Pharmacol; 1976 Sep; 10(5):357-65. PubMed ID: 789084 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cephalosporins in patients with normal or reduced renal function. Andriole VT J Infect Dis; 1978 May; 137 Suppl():S88-S99. PubMed ID: 349098 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of cefapirin in patients with normal and impaired renal functions. Bergan T; Orjavik O; Brodwall EK Arzneimittelforschung; 1981; 31(10):1773-6. PubMed ID: 7198453 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds. Neu HC J Infect Dis; 1978 May; 137 Suppl():S80-S87. PubMed ID: 650006 [TBL] [Abstract][Full Text] [Related]
10. [Cefamandol: pharmacokinetics with normal and impaired renal function (author's transl)]. Höffler D; Moecke D; Sassmann M Dtsch Med Wochenschr; 1978 Aug; 103(34):1334-8. PubMed ID: 679835 [TBL] [Abstract][Full Text] [Related]
11. Effect of probenecid on the blood levels and urinary excretion of cefamandole. Griffith RS; Black HR; Brier GL; Wolny JD Antimicrob Agents Chemother; 1977 May; 11(5):809-12. PubMed ID: 879735 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of cefmetazole in normal subjects and in patients with impaired renal function. Ohkawa M; Orito M; Sugata T; Shimamura M; Sawaki M; Nakashita E; Kuroda K; Sasahara K Antimicrob Agents Chemother; 1980 Sep; 18(3):386-9. PubMed ID: 6932824 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of ceftazidime in normal and impaired renal function. Höffler D; Koeppe P; Williams KJ Arzneimittelforschung; 1984; 34(1):72-6. PubMed ID: 6367755 [TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacokinetics of ceforanide (BL-S786R) and cefazolin in laboratory animals and humans. Lee FH; Pfeffer M; Van Harken DR; Smyth RD; Hottendorf GH Antimicrob Agents Chemother; 1980 Feb; 17(2):188-92. PubMed ID: 7387141 [TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics and safety of high doses of ceforanide (BL-S786R) and cefazolin. Smyth RD; Pfeffer M; Glick A; Van Harken DR; Hottendorf GH Antimicrob Agents Chemother; 1979 Nov; 16(5):615-21. PubMed ID: 526003 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis. Ahern MJ; Finkelstein FO; Andriole VT Antimicrob Agents Chemother; 1976 Sep; 10(3):457-61. PubMed ID: 984787 [TBL] [Abstract][Full Text] [Related]
17. Relationship between pharmacokinetics and bioavailability of cefroxadine (CGP 9000) and renal function. Bergan T; Brodwall EK; Larsen EW Chemotherapy; 1983; 29(3):163-73. PubMed ID: 6872614 [TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacokinetics of cefoperazone and cefamandole. Srinivasan S; Francke EL; Neu HC Antimicrob Agents Chemother; 1981 Feb; 19(2):298-301. PubMed ID: 6214988 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cefamandole in patients with renal failure. Meyers BR; Hirschman SZ Antimicrob Agents Chemother; 1977 Feb; 11(2):248-50. PubMed ID: 848929 [TBL] [Abstract][Full Text] [Related]
20. An overview of pharmacokinetics. Cutler RE Rev Infect Dis; 1984; 6 Suppl 4():S803-8. PubMed ID: 6522921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]